An adiponectin-based short peptide named ADP 355 has high affinity with AdipoR1 and regulates canonical adiponectin signaling pathways (i.e., AMPK, Akt, STAT3, ERK1/2) to halt tumor growth [202,203]. This evidence concerns the gene STAT3 and neoplasm.